Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Can internal dosimetry estimates for different age groups be developed and used in quantitative risk assessment?

0
Posted

Can internal dosimetry estimates for different age groups be developed and used in quantitative risk assessment?

0

To place the analytical results in perspective, the risk characterization will usually try to describe the degree of uncertainty and variability in the analysis. The following questions may be particularly pertinent to such a discussion. Are children more variable in their pharmacokinetic responses than adults? How do we assess and apply this information? The role of variability in the risk assessment process can range from purely qualitatitive (e.g., people are different from one another, so we are not as certain as we would like to be about the degree of risk) to semiquantitative (e.g., people vary considerably in metabolizing chemical X, so it seems prudent to use a half-log toxicokinetic uncertainty factor) to fully quantitative (e.g., we have sufficient individual data to plot the population distribution of effective internal doses per unit of external dose, so let us show the risk manager the cleanup options that protect the 50th, 75th, 90th, and 95th percentiles). The fully quan

0
0

To place the analytical results in perspective, the risk characterization will usually try to describe the degree of uncertainty and variability in the analysis. The following questions may be particularly pertinent to such a discussion. Are children more variable in their pharmacokinetic responses than adults? How do we assess and apply this information? The role of variability in the risk assessment process can range from purely qualitatitive (e.g., people are different from one another, so we are not as certain as we would like to be about the degree of risk) to semiquantitative (e.g., people vary considerably in metabolizing chemical X, so it seems prudent to use a half-log toxicokinetic uncertainty factor) to fully quantitative (e.g., we have sufficient individual data to plot the population distribution of effective internal doses per unit of external dose, so let us show the risk manager the cleanup options that protect the 50th, 75th, 90th, and 95th percentiles). The fully quan

Related Questions

What is your question?

*Sadly, we had to bring back ads too. Hopefully more targeted.

Experts123